Chronic intraperitoneal and oral treatments with hesperidin induce central nervous system effects in mice

Phytotherapy Research

Volumn 26, Issue 2, 2012, Pages 308-312

  Wasowski, Cristina ^a   Loscalzo, Leonardo M ^a   Higgs, Josefina ^a   Marder, Mariel ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

anxiolytic activity; central nervous system; depressant action; hesperidin; intraperitoneal treatment; oral intake

Indexed keywords

HESPERIDIN;

ADULT ANIMAL; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; TRANQUILIZING ACTIVITY;

ADMINISTRATION, ORAL; ANIMALS; CENTRAL NERVOUS SYSTEM; HESPERIDIN; INJECTIONS, INTRAPERITONEAL; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY;

CITRUS; MUS;

EID: 84856278825     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3560     Document Type: Article

References (14)

1. Chiba H, Uehara M, Wu J, et al,. 2003. Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr 133: 1892-1897. (Pubitemid 36666531)
2. Fernández SP, Wasowski C, Paladini AC, Marder M,. 2005. Synergistic interaction between hesperidin, a natural flavonoid, and diazepam. Eur J Pharmacol 512: 189-198. (Pubitemid 40544353)
3. Fernández SP, Wasowski C, Paladini AC, Marder M,. 2006. Central nervous system depressant action of flavonoid glycosides. Eur J Pharmacol 539: 168-176. (Pubitemid 44208813)
4. Guzmán-Gutiérrez SL, Navarrete A,. 2009. Pharmacological exploration of the sedative mechanism of hesperidin identified as the active principle of Citrus sinensis flowers. Planta Med 75: 295-301.
5. Lister RG,. 1987. The use of a plus maze to measure anxiety in the mouse. Psychopharmacology (Berlin) 92: 180-185. (Pubitemid 17072893)
6. Londoño-Londoño J, Lima VR, Jaramillo C, Creczynski-Pasa T,. 2010. Hesperidin and hesperetin membrane interaction: understanding the role of 7-O-glycoside moiety in flavonoids. Arch Biochem Biophys 499: 6-16.
7. Loscalzo LM, Wasowski C, Paladini AC, Marder M,. 2008. Opioid receptors are involved in the sedative and antinociceptive affects of hesperidin as well as in its potentiation with benzodiazepines. Eur J Pharmacol 580: 306-13.
8. Marder M, Viola H, Wasowski C, Fernández S, Medina JH, Paladini AC,. 2003. 6-Methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS. Pharmacol Biochem Behav 75: 737-745.
9. Matsumoto H, Ikoma Y, Sugiura M, Yano M, Hasegawa Y,. 2004. Identification and quantification of the conjugated metabolites derived from orally administered hesperidin in rat plasma. J Agric Food Chem 52: 6653-6659.
10. Nielsen IL, Chee WS, Poulsen L, et al,. 2006. Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: a randomized, double-blind, crossover trial. J Nutr 136: 404-408. (Pubitemid 43228293)
11. Park YB, Do KM, Bok SH, Lee MK, Jeong TS, Choi MS,. 2001. Interactive effect of hesperidin and vitamin E supplements on cholesterol metabolism in high cholesterol-fed rats. Int J Vitam Nutr Res 71: 36-44. (Pubitemid 32205800)
12. Ross JA, Kasum CM,. 2002. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22: 19-34. (Pubitemid 35221452)
13. Spencer JP, Abd-el-Mohsen MM, Rice-Evans C,. 2004. Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Arch Biochem Biophys 423: 148-161. (Pubitemid 38198224)
14. Yamamoto M, Suzuki A, Hase T,. 2008. Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 54: 95-98. (Pubitemid 351413109)